Skip to main content
. 2008 Jul;2(4):568–571. doi: 10.1177/193229680800200406

Figure 1.

Figure 1

Mean plasma insulin levels and glucose infusions rates (baseline corrected) after sc injection of 0.1 IU/kg body weight of a novel rapid-acting insulin (continuous line) in comparison to regular human insulin (broken line) in 14 patients with type 1 diabetes.